Dapagliflozin Impairs the Suppression of Endogenous Glucose Production in Type 2 Diabetes Following Oral Glucose. Alatrach M, Agyin C, Solis-Herrera C, Lavryneko O, et al. Diabetes Care 2022 Mar 2. pii: 144631. doi: 10.2337/dc21-1798.

Read + Share

Amedeo Smart

Independent Medical Education

Alatrach M, Agyin C, Solis-Herrera C, Lavryneko O, et al. Dapagliflozin Impairs the Suppression of Endogenous Glucose Production in Type 2 Diabetes Following Oral Glucose. Diabetes Care 2022 Mar 2. pii: 144631. doi: 10.2337/dc21-1798.
PMID: 35235659